-
New tracing strategy found that the origin of the new coronavirus conforms to the natural evolutionary process
Time of Update: 2021-09-10
" Co-corresponding author of the paper, Zhong Keyuan Institute of Genetics and Developmental Biology Research Associate Huan Qing said the results confirmed mutation of the virus, according to the feasibility of biological characteristics presumption strategy of its history host this calculation .
-
New discovery!
Time of Update: 2021-09-10
Previous studies have shown that the new coronavirus mutates every two weeks, but new research from scientists at the Milner Center for Evolution at the University of Bath and the University of Edinburgh shows that this estimate ignores many mutations that have occurred but have never been sequenced .
-
Chinese scholars have resolved the tubular transport channel protein of mycobacteria
Time of Update: 2021-09-10
Mycobacteria have a very complex envelope structure, including the plasma membrane, cell wall and capsule from the inside to the outside .
Cell localization experiments of Mycobacterium smegmatis confirmed that TiME protein is mainly distributed in the envelope, especially in the outer membrane and capsule .
-
"Price war" alternative play: retrograde high price strategy in the context of centralized procurement
Time of Update: 2021-09-10
Although the prices of the selected brands in the centralized procurement are lower, these consumers have not "empathized" because of the low prices of other brands .
-
Health Commission: 18 newly diagnosed cases of new crown on the 5th are all imported from abroad
Time of Update: 2021-09-10
As of 24:00 on September 5, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are 840 confirmed cases (including 5 severe cases), 89,552 cured and discharged cases, and 4,636 deaths.
-
Is cold chain communication credible?
Time of Update: 2021-09-10
Xu Wenbo, director of the Viral Disease Prevention and Control Institute of the Chinese Center for Disease Control and Prevention, explained that cold chain products contaminated with the new crown virus have infected employees.
-
National Health Commission: The current round of the epidemic in my country has been effectively controlled
Time of Update: 2021-09-10
National Health Commission: The current round of the epidemic in my country has been effectively controlled.
-
CRO and Chinese medicine led the rebound!
Time of Update: 2021-09-10
Chinese medicine stocks are expected to usher in rising opportunities Recently, the semi-annual reports of pharmaceutical companies have been released one after another, and the leading stocks in each sub-industry have maintained a good growth rate and are basically facing good prospects .
-
New market regulations are implemented!
Time of Update: 2021-09-10
Defined: serious According to the facts of the case as determined by the court’s judgment or the administrative punishment of the relevant law enforcement agencies, in the past three years, within the province, there have been acts of giving kickbacks and other medical commercial bribery to medical institutions, centralized procurement institutions and their staff at all levels and in the same case.
-
Health Commission: 23 newly confirmed cases are all imported cases
Time of Update: 2021-09-10
As of 24:00 on August 29, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are 1175 confirmed cases (including 7 severe cases), a total of 89,031 cured and discharged cases, and a total of 4,636 deaths.
-
Who is given the booster shot and how?
Time of Update: 2021-09-10
" Zheng Zhongwei, the leader of the vaccine research and development team of the State Council's Joint Prevention and Control Mechanism Scientific Research Group, gave a set of data: in severe cases People who have completed the immunization program for more than 14 days account for less than 5% of severe cases.
-
Notice on launching outstanding clinical case results solicitation and selection activities
Time of Update: 2021-09-10
Notice on launching outstanding clinical case results solicitation and selection activities Notice on Carrying out Outstanding Clinical Case Achievement Collection and Selection Act
-
The first!
Time of Update: 2021-09-10
This year, Baekje will continue to participate in medical insurance negotiations for the indication of bone metastasis of solid tumors and the prevention of bone-related events in patients with multiple myeloma, with a view to including this indication in medical insurance .
-
Infectious disease expert: anthrax is rarely transmitted from person to person, scientific prevention is the key
Time of Update: 2021-09-10
Mao Xiaorong believes that irregular livestock vaccination, non-strict quarantine and unscientific slaughter methods may be the main causes of anthrax infection .
"Of the cases discovered so far, most of the people infected with anthrax are herders or people who are engaged in breeding and slaughtering cattle, sheep and livestock and selling related products.
-
With nearly $5 billion smashed in two months, can Pfizer's oncology business break through?
Time of Update: 2021-09-10
Accumulated investment of more than 10 billion US dollars betting on oncology business It is understood that Trillium’s main products are two SIRPα-Fc fusion proteins TTI-622 and TTI-621, currently in clinical phase 1b/2, targeting the CD-47-SIRPα pathway, mainly suitable for hematological malignancies .
-
Separating the pharmaceutical sector, Dongyang Sunshine will no longer engage in the production and sales of pharmaceutical products!
Time of Update: 2021-09-10
Through this transaction, Dongyang Sunshine stated that since the company's resource advantages such as talents, technology and channels are mainly concentrated in related fields such as new electronic materials, the future investment of a large amount of resources into Dongyang Sun Pharmaceutical’s transformation and transformation is not conducive to giving full play to its comparative advantages.
-
Entresto's patent war is back!
Time of Update: 2021-09-06
Another company, Nanjing Fangshenghe It is equivalent to a flanking attack on Novartis, and it wants to take a route of "preventing the patent protection of the original research crystal form through the trihydrate" .
-
Junshi Bio will establish a joint venture company for the development of innovative mRNA drugs and vaccines
Time of Update: 2021-09-06
The 50 million yuan in the estimated asset value of the platform will be used to subscribe for 50% of the registered capital of the joint venture company .
-
Concord Kirin Moglizumab Injection is planned to be included in the priority review
Time of Update: 2021-09-06
Based on the results of this research, the FDA approved mogamulizumab in August 2018 to treat adult patients with relapsed or refractory mycosis fungoides or Sezari syndrome who have received at least one systemic therapy .
-
Long-acting C5 inhibitor Ultomiris successfully treats systemic myasthenia gravis Phase 3 clinical success
Time of Update: 2021-09-06
The data showed that the study reached the primary endpoint: at the 26th week of treatment, the total score of the Myasthenia Gravis-Abilities of Daily Living Scale (MG-ADL, a patient report assessment) was highly statistically significant compared to the baseline.
